


BIBAWO Medical A/S Email Formats
Medical Equipment Manufacturing • Birkerød, Capital Region of Denmark, Denmark • 11-20 Employees
BIBAWO Medical A/S Email Formats
BIBAWO Medical A/S uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 42.1% |
{first name}@company.com | john@company.com | 25.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 14.8% |
{first name}{last name}@company.com | johndoe@company.com | 10.2% |
{last name}@company.com | doe@company.com | 7.6% |
Key Contacts at BIBAWO Medical A/S
Finn Jeppesen
Director Development, Manufacturing And Supply
Sandra Helweg Larsen
Qa/Ra Director
Ole Mikkelsen
Director Of Business Development
Company overview
| Headquarters | Klintehøj Vænge 6, Birkerød, Capital Region 3460, DK |
| Website | |
| Founded | 2020 |
| Employees | 11-20 |
About BIBAWO Medical A/S
BIBAWO Medical A/S is a Danish, family-owned company dedicated to supporting healthcare professionals and enhancing patient outcomes through innovation, reliability, and simplicity. Our flagship product, Hydrozid®, is developed in Denmark, manufactured in the EU, and trusted by clinicians worldwide. It offers a modern, portable, and user-friendly solution for cryosurgery—eliminating the complexities of traditional liquid nitrogen systems while delivering effective treatment for a wide range of skin lesions. Hydrozid® combines clinical efficacy with practical ease of use. It is designed for general practitioners, dermatologists, and clinicians operating in both urban and remote or resource-limited settings. Discover how we are redefining cryosurgery at www.hydrozid.eu
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
BIBAWO Medical A/S has 9 employees across 4 departments.
Departments
Number of employees
Funding Data
BIBAWO Medical A/S has never raised funding before.
Frequently asked questions
4.8
40,000 users



